Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing.

Vambe D, Kay A, Ziyane M, Thunzini M, Thi SS, de Araujo L, Dreyer V, Niemann T, Sibandze B, Masina S, Cabibbe AM, Furin J, Mazuruse T, Dlamini L, Jele T, Mamba B, Maphalala G, Dlamini M, Dube M, Lukhele N, Cirillo DM, Mandalakas A, Lange C, Ngwenya S, Utpatel C, Dlamini S, Niemann S

Open source

DOI: 10.1038/s41467-026-73551-w
Published: 2026 Jun 11
Container: Nature communications
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-026-73551-w,
  title = {Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing.},
  author = {Vambe D and Kay A and Ziyane M and Thunzini M and Thi SS and de Araujo L and Dreyer V and Niemann T and Sibandze B and Masina S and Cabibbe AM and Furin J and Mazuruse T and Dlamini L and Jele T and Mamba B and Maphalala G and Dlamini M and Dube M and Lukhele N and Cirillo DM and Mandalakas A and Lange C and Ngwenya S and Utpatel C and Dlamini S and Niemann S},
  year = {2026},
  journal = {Nature communications},
  doi = {10.1038/s41467-026-73551-w},
  url = {https://doi.org/10.1038/s41467-026-73551-w}
}

RIS

TY  - JOUR
TI  - Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing.
AU  - Vambe D
AU  - Kay A
AU  - Ziyane M
AU  - Thunzini M
AU  - Thi SS
AU  - de Araujo L
AU  - Dreyer V
AU  - Niemann T
AU  - Sibandze B
AU  - Masina S
AU  - Cabibbe AM
AU  - Furin J
AU  - Mazuruse T
AU  - Dlamini L
AU  - Jele T
AU  - Mamba B
AU  - Maphalala G
AU  - Dlamini M
AU  - Dube M
AU  - Lukhele N
AU  - Cirillo DM
AU  - Mandalakas A
AU  - Lange C
AU  - Ngwenya S
AU  - Utpatel C
AU  - Dlamini S
AU  - Niemann S
PY  - 2026
JO  - Nature communications
DO  - 10.1038/s41467-026-73551-w
UR  - https://doi.org/10.1038/s41467-026-73551-w
ER  -

APA

D, V., A, K., M, Z., M, T., SS, T., L, D. A., V, D., T, N., B, S., S, M., AM, C., J, F., T, M., L, D., T, J., B, M., G, M., M, D., M, D., N, L., DM, C., A, M., C, L., S, N., C, U., S, D., & S, N. (2026). Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing.. Nature communications. https://doi.org/10.1038/s41467-026-73551-w

Source records

pubmed · retrieved 2026-09-26T08:22:01.798Z
europe-pmc · retrieved 2026-09-26T08:22:01.824Z
doaj · retrieved 2026-09-26T08:22:01.804Z